Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1

Neuro-Oncology

Volumn 15, Issue 8, 2013, Pages 1088-1095

  De Blank, Peter Matthew Kennedy ^a   Berman, Jeffrey Ira ^b   Liu, Grant T ^c   Roberts, Timothy Paul Leslie ^b   Fisher, Michael Jay ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

diffusion tensor imaging; neuro ophthalmology; neurofibromatosis type 1; optic pathway glioma; visual acuity

Indexed keywords

AGE; ARTICLE; BRAIN TISSUE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE CANCER; EYE EXAMINATION; FEMALE; FRACTIONAL ANISOTROPY; GLIOMA; HUMAN; MALE; MEDICAL RECORD REVIEW; NEUROFIBROMATOSIS; OPTIC PATHWAY GLIOMA; RETROSPECTIVE STUDY; SCHOOL CHILD; VISUAL ACUITY; VISUAL IMPAIRMENT; WHITE MATTER;

DIFFUSION TENSOR IMAGING; NEURO-OPHTHALMOLOGY; NEUROFIBROMATOSIS TYPE 1; OPTIC PATHWAY GLIOMA; VISUAL ACUITY;

ANISOTROPY; CHILD; CROSS-SECTIONAL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA; PROGNOSIS; RETROSPECTIVE STUDIES; VISION DISORDERS; VISUAL ACUITY; VISUAL PATHWAYS;

EID: 84880650871     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not068     Document Type: Article

References (27)

1. Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005;141(1):71-74. (Pubitemid 40144442)
2. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type1: a longitudinal study. J Pediatr. 1994;125:63-66. (Pubitemid 24225179)
3. Listernick R, Charrow J, Greenwald MJ, Esterly NB. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. 1989;114(5): 788-792. (Pubitemid 19122974)
4. Balcer LJ, Liu GT, Heller G, et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol. 2001;131: 442-445. (Pubitemid 32273429)
5. King A, Listernick R, Charrow J, Piersall L, Gutmann DH. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet A. 2003;122A(2):95-99. (Pubitemid 37122276)
6. Fisher MJ, Loguidice M, Gutmann DH, et al. Visual outcomes in children withneurofibromatosistype 1-associated optic pathwaygliomafollowing chemotherapy: a multicenter retrospective analysis. Neuro Oncol. 2012;14(6):790-797.
7. Shofty B, Ben-Sira L, Freedman S, et al. Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer. 2011;57(3):481-485.
8. Pilling RF, Lloyd IC, Huson S. Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit. Eye (Lond). 2010;24(10):1603-1605.
9. North KN, Riccardi V, Samango-Sprouse C, et al. Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology. 1997;48(4): 1121-1127.
10. Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005;65(7):1037-1044. (Pubitemid 41429628)
11. Mitchell AE, Elder JE, Mackey DA, Waters KD, Ashley DM. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas. J Pediatr Hematol Oncol. 2001;23(9): 572-577. (Pubitemid 34073861)
12. Campagna M, Opocher E, Viscardi E, et al. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer. 2010;55(6):1083-1088.
13. Tibbetts MD, Shah CP, Young LH, Duker JS, Maguire JI, Morley MG. Treatment of acute retinal necrosis. Ophthalmology. 2010;117(4): 818-824.
14. Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007;61(3):189-198. (Pubitemid 46557343)
15. Jiang H, van Zijl PC, Kim J, Pearlson GD, Mori S. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed. 2006;81(2):106-116. (Pubitemid 43144442)
16. Hegedus B, Hughes FW, Garbow JR, et al. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma. J Neuropathol Exp Neurol. 2009;68(5):542-551.
17. Nickerson JP, Salmela MB, Koski CJ, Andrews T, Filippi CG. Diffusion tensor imaging of the pediatric optic nerve: intrinsic and extrinsic pathology compared to normal controls. J Magn Reson Imaging. 2010;32(1):76-81.
18. Filippi CG, Bos A, Nickerson JP, Salmela MB, Koski CJ, Cauley KA. Magnetic resonance diffusion tensor imaging (MRDTI) of the optic nerve and optic radiations at 3T in children with neurofibromatosis type I (NF-1). Pediatr Radiol. 2012;42(2):168-174.
19. Lober RM, Guzman R, Cheshier SH, Fredrick DR, Edwards MS, Yeom KW. Application of diffusion tensor tractography in pediatric optic pathway glioma. J Neurosurg Pediatr. 2012;0:0-0.
20. Hickman SJ. Optic nerve imaging in multiple sclerosis. J Neuroimaging. 2007;17(Suppl 1):42S-45S. (Pubitemid 46558268)
21. Vinogradov E, Degenhardt A, Smith D, et al. High-resolution anatomic, diffusion tensor, and magnetization transfer magnetic resonance imaging of the optic chiasm at 3T. J Magn Reson Imaging. 2005;22(2):302-306. (Pubitemid 41045446)
22. Beatty RM, Sadun AA, Smith L, Vonsattel JP, Richardson EP, Jr. Direct demonstration of transsynaptic degeneration in the human visual system: a comparison of retrograde and anterograde changes. J Neurol Neurosurg Psychiatry. 1982;45(2):143-146. (Pubitemid 12176930)
23. Naismith RT, Xu J, Tutlam NT, et al. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology. 2010;74(21):1694-1701.
24. Mesaros S, Rocca MA, Pagani E, et al. Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years. AJNR Am J Neuroradiol. 2011;32(6):1016-1020.
25. Ng Y, North KN. Visual-evoked potentials in the assessment of optic gliomas. Pediatr Neurol. 2001;24:44-48. (Pubitemid 32140935)
26. Moharir M, London K, Howman-Giles R, North K. Utility of positronemission tomography for tumour surveillance in children with neurofibromatosis type 1. Eur J Nucl Med Mol Imaging. 2010;37(7):1309-1317.
27. Avery RA, Liu GT, Fisher MJ, et al. Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol. 2011; 151(3):542-549 e542.